<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Lifetech Scientific Corp — News on 6ix</title>
<link>https://6ix.com/company/lifetech-scientific-corp</link>
<description>Latest news and press releases for Lifetech Scientific Corp on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 31 Mar 2026 16:40:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/lifetech-scientific-corp" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6836859678dffbe2df16a219.webp</url>
<title>Lifetech Scientific Corp</title>
<link>https://6ix.com/company/lifetech-scientific-corp</link>
</image>
<item>
<title>LifeTech Scientific Corporation Announces 2025 Annual Results: Steady Revenue Growth with Adjusted Net Profit Increasing 24.9%</title>
<link>https://6ix.com/company/lifetech-scientific-corp/news/lifetech-scientific-corporation-announces-2025-annual-results-steady-revenue-growth-with-adjusted-net-profit-increasing-249percent</link>
<guid isPermaLink="true">https://6ix.com/company/lifetech-scientific-corp/news/lifetech-scientific-corporation-announces-2025-annual-results-steady-revenue-growth-with-adjusted-net-profit-increasing-249percent</guid>
<pubDate>Tue, 31 Mar 2026 16:40:00 GMT</pubDate>
<description>LifeTech Scientific Corporation ("LifeTech" or the "Company", together with its subsidiaries, the "Group"; stock code: 1302.HK), a leading medical device company specializing in minimally invasive interventional solutions for cardio-cerebrovascular and peripheral vascular diseases, today announced its audited consolidated results for the year ended 31 December 2025 (the "Reporting Period").</description>
</item>
<item>
<title>LifeTech Scientific Corporation Announces 2025 Interim Results: Core Business Demonstrated Resilience, Domestic and Overseas Sales Both Increased</title>
<link>https://6ix.com/company/lifetech-scientific-corp/news/lifetech-scientific-corporation-announces-2025-interim-results-core-business-demonstrated-resilience-domestic-and-overseas-sales-both-increased</link>
<guid isPermaLink="true">https://6ix.com/company/lifetech-scientific-corp/news/lifetech-scientific-corporation-announces-2025-interim-results-core-business-demonstrated-resilience-domestic-and-overseas-sales-both-increased</guid>
<pubDate>Fri, 29 Aug 2025 17:07:00 GMT</pubDate>
<description>LifeTech Scientific Corporation ("LifeTech" or the "Company", together with its subsidiaries, the "Group", stock code: 1302.HK), a medical device company specializing in minimally invasive interventional solutions for cardio-cerebrovascular and peripheral vascular diseases, today announced its unaudited consolidated results for the six months ended 30 June 2025 (the "Reporting Period").</description>
</item>
<item>
<title>LifeTech Scientific Corporation Announced 2024 Annual Results: Revenue Exceeded RMB1.3 billion, and International Business Increased by 26%</title>
<link>https://6ix.com/company/lifetech-scientific-corp/news/lifetech-scientific-corporation-announced-2024-annual-results-revenue-exceeded-rmb13-billion-and-international-business-increased-by-26percent</link>
<guid isPermaLink="true">https://6ix.com/company/lifetech-scientific-corp/news/lifetech-scientific-corporation-announced-2024-annual-results-revenue-exceeded-rmb13-billion-and-international-business-increased-by-26percent</guid>
<pubDate>Sat, 29 Mar 2025 17:02:00 GMT</pubDate>
<description>LifeTech Scientific Corporation (the "Company" or "LifeTech", Stock code: 1302.HK), a company specializing in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, together with its subsidiaries (the "Group") announced the audited consolidated results for the year ended 31 December 2024 (the "Reporting Period").</description>
</item>
</channel>
</rss>